Cardinal Health (NYSE:CAH) Price Target Increased to $125.00 by Analysts at UBS Group

Cardinal Health (NYSE:CAH) had its price target raised by UBS Group from $120.00 to $125.00 in a research note published on Thursday, Benzinga reports. UBS Group currently has a buy rating on the stock.

CAH has been the subject of several other reports. Argus cut their target price on shares of Cardinal Health from $120.00 to $115.00 and set a buy rating for the company in a research report on Wednesday, May 15th. Evercore ISI increased their price objective on Cardinal Health from $105.00 to $115.00 and gave the company an in-line rating in a research report on Thursday. Citigroup dropped their target price on Cardinal Health from $115.00 to $107.00 and set a neutral rating for the company in a research report on Friday, July 19th. Wells Fargo & Company reduced their price target on shares of Cardinal Health from $96.00 to $94.00 and set an underweight rating on the stock in a research report on Monday, April 29th. Finally, StockNews.com downgraded shares of Cardinal Health from a strong-buy rating to a buy rating in a research note on Thursday, August 8th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of Hold and an average price target of $113.69.

Cardinal Health Trading Up 1.3 %

Shares of CAH stock traded up $1.37 during trading hours on Thursday, reaching $109.28. The stock had a trading volume of 1,019,746 shares, compared to its average volume of 2,145,313. Cardinal Health has a 12 month low of $85.11 and a 12 month high of $116.04. The firm has a market capitalization of $26.62 billion, a PE ratio of 48.53, a PEG ratio of 1.14 and a beta of 0.61. The stock’s fifty day simple moving average is $99.15 and its 200 day simple moving average is $103.21.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.10. The firm had revenue of $59.87 billion during the quarter, compared to the consensus estimate of $58.74 billion. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter last year, the company posted $1.55 EPS. As a group, equities research analysts anticipate that Cardinal Health will post 7.35 EPS for the current fiscal year.

Institutional Trading of Cardinal Health

Several large investors have recently modified their holdings of the business. Norges Bank bought a new position in shares of Cardinal Health during the fourth quarter valued at approximately $258,499,000. Point72 Asset Management L.P. purchased a new stake in shares of Cardinal Health in the 2nd quarter worth about $90,440,000. California Public Employees Retirement System boosted its stake in shares of Cardinal Health by 118.9% during the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after purchasing an additional 823,520 shares in the last quarter. Acadian Asset Management LLC boosted its stake in shares of Cardinal Health by 19.1% during the 1st quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock valued at $416,585,000 after purchasing an additional 598,002 shares in the last quarter. Finally, Jupiter Asset Management Ltd. purchased a new position in shares of Cardinal Health during the first quarter valued at about $56,454,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.